Healthcare provider profile · identity verified

Russell Hal Gerry, MD

Internal Medicine · WILMINGTON, NC · NPI 1811992340

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	391	49
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	282	28
Oxycodone Hcl	Oxycodone Hcl	279	32
Gabapentin	Gabapentin	227	32
Alprazolam	Alprazolam	221	33
Clonazepam	Clonazepam	210	31
Trazodone Hcl	Trazodone Hcl	157	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	143	18
Zolpidem Tartrate	Zolpidem Tartrate	127	22
Albuterol Sulfate Hfa	Albuterol Sulfate	102	28
Levothyroxine Sodium	Levothyroxine Sodium	99	26
Metoprolol Succinate	Metoprolol Succinate	98	24
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	96	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	95	25
Quetiapine Fumarate	Quetiapine Fumarate	88	13
Fluoxetine Hcl	Fluoxetine Hcl	87	19
Citalopram Hbr	Citalopram Hydrobromide	84	18
Tramadol Hcl	Tramadol Hcl	83	suppressed
Pregabalin	Pregabalin	82	14
Sumatriptan Succinate	Sumatriptan Succinate	81	suppressed
Ibuprofen	Ibuprofen	79	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	78	26
Atorvastatin Calcium	Atorvastatin Calcium	74	22
Sertraline Hcl	Sertraline Hcl	73	13
Bupropion Xl	Bupropion Hcl	70	19
Amlodipine Besylate	Amlodipine Besylate	65	19
Hydroxyzine Pamoate	Hydroxyzine Pamoate	65	14
Oxycontin	Oxycodone Hcl	62	suppressed
Topiramate	Topiramate	59	suppressed
Carisoprodol	Carisoprodol	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	18
Fluticasone Propionate	Fluticasone Propionate	54	19
Lisinopril	Lisinopril	54	15
Buprenorphine Hcl	Buprenorphine Hcl	53	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Omeprazole	Omeprazole	53	15
Esomeprazole Magnesium	Esomeprazole Magnesium	51	suppressed
Prednisone	Prednisone	51	25
Buspirone Hcl	Buspirone Hcl	49	suppressed
Meloxicam	Meloxicam	49	12
Rosuvastatin Calcium	Rosuvastatin Calcium	47	12
Metformin Hcl	Metformin Hcl	46	14
Clonidine Hcl	Clonidine Hcl	45	11
Lamotrigine	Lamotrigine	44	11
Tamsulosin Hcl	Tamsulosin Hcl	44	14
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Ondansetron Odt	Ondansetron	38	suppressed
Ozempic	Semaglutide	38	suppressed
Potassium Chloride	Potassium Chloride	38	12
Promethazine Hcl	Promethazine Hcl	38	suppressed
Furosemide	Furosemide	37	11
Ondansetron Hcl	Ondansetron Hcl	37	11
Simvastatin	Simvastatin	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	suppressed
Diazepam	Diazepam	35	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Finasteride	Finasteride	33	suppressed
Famotidine	Famotidine	32	suppressed
Azithromycin	Azithromycin	29	26
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Fluconazole	Fluconazole	22	12
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Linzess	Linaclotide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Ibu	Ibuprofen	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Movantik	Naloxegol Oxalate	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Olanzapine	Olanzapine	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Glipizide Er	Glipizide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Baclofen	Baclofen	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Xtampza Er	Oxycodone Myristate	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Risperidone	Risperidone	13	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Eliquis	Apixaban	12	suppressed
Losartan Potassium	Losartan Potassium	12	suppressed
Nystop	Nystatin	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Abilify Maintena	Aripiprazole	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error